Certificate in Cancer Immunotherapy- SITC-G

CP2_-_Copy.png

The Society for Immunotherapy of Cancer (SITC) is pleased to offer physicians and qualified healthcare providers the opportunity to earn a Certificate in Cancer Immunotherapy, supporting their knowledge and skills to provide effective and safe care for patients treated with cancer immunotherapy. Learners can expect to develop a comprehensive understanding of cancer immunotherapies, including checkpoint inhibitors, cell therapies and many others, as well as the management of side effects, allowing them to successfully implement immunotherapy in clinical practice.  

The Certificate in Cancer Immunotherapy consists of eight learning modules and a final assessment. You will earn SITC Graduate in Cancer Immunotherapy (SITC-G) certificate upon successfully completing all the 8 modules and qualfying in the final assessment. The SITC-G certificate identifies a healthcare provider as completing specialized training in cancer immunotherapy.  All modules are approved for CME, CNE, CPE and MOC credits, except where noted.

 

 

Certificate- SITC Graduate in Cancer Immunotherapy / SITC-G

CP1.png




 

 

 

Cost of certification

  • SITC Member Price: $200
  • Non-Member Price: $250

 

Target Audiences

The primary target audience for the program is treating physicians (U.S. licensed MD / DO or global equivalent). The courses and earning of the certificate will also be available to practicing, licensed NPs, PAs, and PharmDs (or RPh degree holders involved in direct clinical services), or global equivalent. The courses will be available to those who are not practicing clinicians, but they will not be eligible to earn the certificate.

Requirements

The requirements to earn the certificate include:

  • Must be a treating physician (U.S. licensed MD / DO or global equivalent), or a practicing licensed NP, PA, PharmD or RPh degree holder involved in direct clinical services, or global equivalent
  • Complete the coursework (all eight modules)
    • anticipated to be approximately 1 hour each, for a total of 8 hours
  • Pass all end-of-module assessments
  • Successfully complete a comprehensive exam covering all modules

 

Certificate Term

The certificate term is two years. Then, to earn a current certificate, which allows one to continue to use the SITC-G designation, an individual will need to take and pass updated coursework and assessments. If one misses the deadline for reissuance, he or she will need to retake and pass the full program.
 

 

Certificate Program Task Force

Chair

Robert L. Ferris, MD, PhD – University of Pittsburgh Medical Center Hillman Cancer Center

 

Members

  • Leisha Emens, MD, PhD – University of Pittsburgh Medical Center Hillman Cancer Center
  • Umar Farooq, MD – University of Iowa
  • Silvia Formenti, MD – Weill Cornell Medicine
  • Sigrun Hallmeyer, MD – Advocate Medical Group
  • Howard Kaufman, MD, FACS – Ankyra Therapeutics/Massachusetts General Hospital
  • Jose Lutzky, MD, FACP – University of Miami Sylvester Cancer Center
  • George Weiner, MD – University of Iowa

 

 

Requirements

The requirements to earn the certificate include:
• Complete the coursework (all eight modules)—anticipated to be approximately 1.5 hours each for a total of 12–16 hours
• Successfully complete a comprehensive exam covering all modules

 

 

Learner Notification

This program consists of eight modules. Continuing Education credit information for the modules can be found below, and at the module level. Please note, that each module counts for a maximum of 1.50 AMA PRA Category 1 Credits™ for physicians and 1.50 contact hours for nurses and 1.50 knowledge-based contact hours for pharmacists. 

CONTINUING EDUCATION (CE) LANGUAGE

Certificate in Cancer Immunotherapy Webseries Online

Physicians / Nurses / Pharmacists

download.png In support of improving patient care, this activity has been planned and implemented by Amedco LLC and SITC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Credit Designation Statement – Amedco LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM for physicians and 1.50 contact hours for nurses and 1.50 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.


ABIM MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Part 2 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

Module 1: Basic Immunology Concepts

The module 1 Basic Immunology Concepts will cover some of the key immunology needed to understand the rest of the certificate program.

Speaker Information
Robert Ferris MD, PhD  [ view bio ]
Module 2: Basic Cancer Immunotherapy Concepts

The module 2 Basic Cancer Immunotherapy Concepts will cover the biological foundation of cancer immunotherapy, applying the basic immunology you learned in the last module to help lay the foundation for future topics in this program.

Speaker Information
Hussein Tawbi MD, PhD  [ view bio ]
Module 3: Immune Checkpoint Blockade

Module 3 Immune Checkpoint Blockade will cover the biological foundation of immune checkpoint blockade therapies as well as diving into their clinical use.

Speaker Information
Robert Ferris MD, PhD  [ view bio ]
Module 4 A: Managing Immune Checkpoint Inhibitor Adverse Events

Module 4 Managing Immune Checkpoint Inhibitor Adverse Events will cover the presentations, diagnosis and management of adverse events resulting from immune checkpoint inhibitor treatments. This module is broken down into 2 separate modules. The combined test for both the modules can be attempted at the end of Module 4 B.

 

Speaker Information
Jason Luke MD, FACP  [ view bio ]
Module 4 B: Managing Immune Checkpoint Inhibitor Adverse Events

Module 4 B, Managing Immune Checkpoint Inhibitor Adverse Events is the second half of the module 4. In this module, we will discuss additional toxicities that may occur with immune checkpoint inhibitor therapy  and some special considerations for treatment.

Speaker Information
Jason Luke MD, FACP  [ view bio ]
Module 5: Other Approaches (Cytokines, Vaccines, and Immune Cell Engagers)

Module 5 Other Approaches (Cytokines, Vaccines, and Immune Cell Engagers) will cover the biological foundation and clinical implementation of cytokines, vaccines and immune cell engagers as immunotherapies for cancer, including adverse event management.

 

Speaker Information
James Gulley MD, PhD, FACP  [ view bio ]
Francesco Marincola MD  [ view bio ]
Module 6: Oncolytic Viruses and Intralesional Therapy

Module 6 Oncolytic Viruses and Local Therapy will cover the biological foundation and clinical implementation of intratumoral therapies and oncolytic viruses.

Speaker Information
Brian Gastman MD  [ view bio ]
Ann Silk MD, MS  [ view bio ]
Module 7: CAR T Cell and Cellular Therapy

Module 7 CAR T Cell and Cellular Therapy will cover the mechanisms and clinical administration of cellular therapies for cancer, including an emphasis on adverse event management.

 

Speaker Information
Carl June MD  [ view bio ]
Module 8: Implementing Cancer Immunotherapy in Clinical Practice

Module 8, Implementing Cancer Immunotherapy in Clinical Practice will cover the practical aspects of instituting immunotherapy treatments in a clinical practice, such as education considerations, value-based care, and access to patient and provider resources.

 

Speaker Information
Sigrun Hallmeyer MD  [ view bio ]
Assessment- Certificate in Cancer Immunotherapy

You have completed all your modules for Certificate in Cancer Immunotherapy and now is the time for the final assessment. The final assessment consists of 80 multiple choice questions that test on all 8 modules of content. To pass the final assessment, you must receive a grade of 80% or above. You will have 3 attempts and 65 minutes to complete the test in full. If you do not successfully complete the final assessment in those parameters, SITC will require you to go through the modules of content again - please email education@sitcancer.org to have the content reset for you.

You will be presented with statements or questions with multiple options. Please select the appropriate option/ options for the given statement / question. Once done, please click submit.

For any questions, please reach out to education@sitcancer.org.

Individual topic purchase: Selected
SITC-G Final Certificate
Certificate of Completion: 0.00
Products
Certificate in Cancer Immunotherapy- SITC-G
SITC Member Price:$200.00
Non-Member Price:$250.00